Bio Essence (BIOE) Operating Margin Growth (1y) (2021 - 2026)
Bio Essence (BIOE) Operating Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 304.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -157.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -650.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -2,102.00 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1,962.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 152.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -12,673.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -2,276.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -583.00 |
| 10 | Bio Essence | - | - | 319,353.00 | 96,741.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 96,741.00 |
| Dec 31, 2025 | 6,698.00 |
| Sep 30, 2025 | 11,915.00 |
| Jun 30, 2025 | 41,939.00 |
| Mar 31, 2025 | -82,562.00 |
| Dec 31, 2024 | -9,270.00 |
| Sep 30, 2024 | -5,565.00 |
| Jun 30, 2024 | -37,913.00 |
| Mar 31, 2024 | -9,155.00 |
| Dec 31, 2023 | 13,395.00 |
| Sep 30, 2023 | 4,719.00 |
| Jun 30, 2023 | 3,748.00 |
| Mar 31, 2023 | 6,678.00 |
| Dec 31, 2022 | 5,466.00 |
| Sep 30, 2022 | -1,527.00 |
| Jun 30, 2022 | 5,665.00 |
| Mar 31, 2022 | 2,257.00 |
| Dec 31, 2021 | 5,689.00 |
| Sep 30, 2021 | -304.00 |
| Jun 30, 2021 | -1,506.00 |